First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 1, 2013, Pages 64-68

  Zhang, Xia ^a   Hu, Qiwen ^a   Yuan, Wenchang ^a   Shang, Weilong ^a   Cheng, Hang ^a   Yuan, Jizhen ^a   Zhu, Junmin ^a   Hu, Zhen ^a   Li, Shu ^a   Chen, Wei ^a   Hu, Xiaomei ^a   Rao, Xiancai ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

MRSA; Vancomycin; VISA

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; DEXAMETHASONE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BURN; CASE REPORT; CHINA; CONTROLLED STUDY; DERMATITIS; DRUG DOSE INCREASE; ESCHERICHIA COLI; GENE CASSETTE; GENE SEQUENCE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SKIN INJURY; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

EID: 84881551956     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.06.008     Document Type: Article

References (25)

1. Aires-de-Sousa M., Boye K., de Lencastre H., Deplano A., Enright M.C., Etienne J., et al. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol 2006, 44(2):619-621.
2. Cheng H., Yuan W., Zeng F., Hu Q., Shang W., Tang D., et al. Molecular and phenotypic evidence for the spread of three major methicillin-resistant Staphylococcus aureus clones associated with two characteristic antimicrobial resistance profiles in China. J Antimicrob Chemother 2013, 10.1093/jac/dkt213.
3. Chung M., de Lencastre H., Matthews P., Tomasz A., Adamsson I., Aires de Sousa M., et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist 2000, 6(3):189-198.
4. Chung G., Cha J., Han S., Jang H., Lee K., Yoo J., et al. Nationwide surveillance study of vancomycin intermediate Staphylococcus aureus strains in Korean hospitals from 2001 to 2006. J Microbiol Biotechnol 2010, 20(3):637-642.
5. Chung D.R., Baek J.Y., Kim H.A., Lim M.H., Kim S.H., Ko K.S., et al. First report of vancomycin-intermediate resistance in sequence type 72 community genotype methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2012, 50(7):2513-2514.
6. Performance standards for Antimicrobial Susceptibility Testing; Twenty-First Information Supplement. CLSI document M100-S21 2011, Clinical and Laboratory Standards Institute, Wayne, PA.
7. Cui L., Ma X., Sato K., Okuma K., Tenover F.C., Mamizuka E.M., et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003, 41(1):5-14.
8. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38(3):1008-1015.
9. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997, 350(9092):1670-1673.
10. Howden B.P., Smith D.J., Mansell A., Johnson P.D., Ward P.B., Stinear T.P., Davies J.K. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia. BMC Microbiol 2008, 8:39.
11. Howden B.P., Davies J.K., Johnson P.D., Stinear T.P., Grayson M.L. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010, 23(1):99-139.
12. Kobayashi N., Wu H., Kojima K., Taniguchi K., Urasawa S., Uehara N., et al. Detection of mecA, femA, and femB genes in clinical strains of staphylococci using polymerase chain reaction. Epidemiol Infect 1994, 113(2):259-266.
13. Liu Y., Wang H., Du N., Shen E., Chen H., Niu J., et al. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother 2009, 53(2):512-518.
14. Lu J.J., Lee S.Y., Hwa S.Y., Yang A.H. Septic arthritis caused by vancomycin-intermediate Staphylococcus aureus. J Clin Microbiol 2005, 43(8):4156-4158.
15. Milheirico C., Oliveira D.C., de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother 2007, 51(9):3374-3377.
16. Nimmo G.R., Coombs G.W., Pearson J.C., O'Brien F.G., Christiansen K.J., Turnidge J.D., et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006, 184(8):384-388.
17. Passalacqua K.D., Satola S.W., Crispell E.K., Read T.D. A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin. Antimicrob Agents Chemother 2012, 56:5212-5223.
18. Patel R., Rouse M.S., Piper K.E., Cockerill F.R., Steckelberg J.M. In vitro activity of LY333328 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and penicillin-resistant Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1998, 30(2):89-92.
19. Pillai S.K., Wennersten C., Venkataraman L., Eliopoulos G.M., Moellering R.C., Karchmer A.W. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus. Clin Infect Dis 2009, 49(8):1169-1174.
20. Ramos-Trujillo E., Perez-Roth E., Mendez-Alvarez S., Claverie-Martin F. Multiplex PCR for simultaneous detection of enterococcal genes vanA and vanB and staphylococcal genes mecA, ileS-2 and femB. Int Microbiol 2003, 6(2):113-115.
21. Smith T.L., Pearson M.L., Wilcox K.R., Cruz C., Lancaster M.V., Robinson-Dunn B., et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999, 340(7):493-501.
22. Sun W., Chen H., Liu Y., Zhao C., Nichols W.W., Chen M., et al. Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China. Antimicrob Agents Chemother 2009, 53(9):3642-3649.
23. Wong S.S., Ho P.L., Woo P.C., Yuen K.Y. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 1999, 29(4):760-767.
24. Yamamoto T., Nishiyama A., Takano T., Yabe S., Higuchi W., Razvina O., Shi D. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. J Infect Chemother 2010, 16(4):225-254.
25. Yuan W., Hu Q., Cheng H., Shang W., Liu N., Hua Z., et al. Cell wall thickening is associated with adaptive resistance to amikacin in methicillin-resistant Staphylococcus aureus clinical isolates. J Antimicrob Chemother 2013, 68(5):1089-1096.